851225-34-8

Basic information

• Product Name: 1-{2-methyl-4-[3-(4-trifluoromethoxyphenyl)[1,2,4]thiadiazol-5-ylmethylsulfanyl]phenoxy}cyclopentanecarboxylic acid methyl ester
• Synonyms: 1-{2-methyl-4-[3-(4-trifluoromethoxyphenyl)[1,2,4]thiadiazol-5-ylmethylsulfanyl]phenoxy}cyclopentanecarboxylic acid methyl ester
• CAS NO: 851225-34-8
• Molecular Weight: 524.585
• Mol File: 851225-34-8.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: 1-{2-methyl-4-[3-(4-trifluoromethoxyphenyl)[1,2,4]thiadiazol-5-ylmethylsulfanyl]phenoxy}cyclopentanecarboxylic acid methyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: 1-{2-methyl-4-[3-(4-trifluoromethoxyphenyl)[1,2,4]thiadiazol-5-ylmethylsulfanyl]phenoxy}cyclopentanecarboxylic acid methyl ester(851225-34-8)
• EPA Substance Registry System: 1-{2-methyl-4-[3-(4-trifluoromethoxyphenyl)[1,2,4]thiadiazol-5-ylmethylsulfanyl]phenoxy}cyclopentanecarboxylic acid methyl ester(851225-34-8)

Safety Data

• Hazardous Substances Data: 851225-34-8(Hazardous Substances Data)

Upstream product

• 851224-90-3 5-bromomethyl-3-(4-trifluoromethoxyphenyl)[1,2,4]thiadiazole 
• 851225-32-6 1-(2-methyl-4-triisopropylsilanylsulfanylphenoxy)cyclopentanecarboxylic acid methyl ester 
• 456-71-3 4-trifluoromethoxybenzamide 
• 95-48-7 ortho-cresol 
• 3400-45-1 cyclopentanecarboxylic acid 
• 51572-54-4 methyl 1-bromocyclopentanecarboxylate 
• 851225-31-5 1-(4-bromo-2-methylphenoxy)cyclopentanecarboxylic acid methyl ester 
• 851225-30-4 1-o-tolyloxycyclopentanecarboxylic acid methyl ester 
• 851224-89-0 [3-(4-trifluoromethoxyphenyl)[1,2,4]thiadiazol-5-yl]methanol 
• 851224-88-9 3-(4-trifluoromethoxyphenyl)[1,2,4]thiadiazole-5-carboxylic acid ethyl ester 

Relevant articles and documents

Synthesis and identification of [1,2,4]thiadiazole derivatives as a new series of potent and orally active dual agonists of peroxisome proliferator-activated receptors α and δ

Cardiovascular disease is the most common cause of morbidity and mortality in developed nations. To effectively target dyslipidemia to reduce the risk of cardiovascular disease, it may be beneficial to activate the peroxisome proliferator-activated recept